KK

Kumar Kumarapuram Subramanyam

Director Whole-Time Director DIN 07116992
DIN 07116992 First appointment Mar 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Mar 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Kumar Kumarapuram Subramanyam

Data last updated:

Kumar Kumarapuram Subramanyam was a Whole-Time Director at Mylan Pharmaceuticals Private Limited (2015–2017). The company operates in Pharma.

DIN 07116992
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 31 Mar 2015

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director31 Mar 20151997₹1,253 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mylan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kumar Kumarapuram Subramanyam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumar Kumarapuram Subramanyam

Kumar Kumarapuram Subramanyam was first appointed on 31 Mar 2015 as Whole-Time Director at Mylan Pharmaceuticals Private Limited.

Kumar Kumarapuram Subramanyam held 1 earlier board appointment: Mylan Pharmaceuticals Private Limited (Whole-Time Director, 31 Mar 2015 to 13 Nov 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available